Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2011 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Asset Utilization Ratio came in at 0.73 in Q2 2026, up 13.12% on a YoY basis from 0.64 in Q2 2025, and up 12.12% quarter-over-quarter from 0.65 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Asset Utilization Ratio for 14 consecutive years, with 0.73 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio rose 13.12% year-over-year to 0.73; the trailing twelve-month figure through Apr 2026 stood at 0.73 (up 13.12% YoY), and the FY2025 full-year result was 0.6, up 14.41% from the prior year.
- Asset Utilization Ratio grew to 0.73 in Q2 2026 per PBSV's latest filing, from 0.65 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.01 in Q3 2022 and bottomed at 0.58 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.77 across 5 years, with a median of 0.75 in 2024.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio jumped 45.34% in 2022, then slumped 30.95% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.95 in 2022, then decreased by 10.78% to 0.84 in 2023, then plunged by 30.95% to 0.58 in 2024, then climbed by 13.32% to 0.66 in 2025, then gained by 10.07% to 0.73 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.73, 0.65, and 0.66 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 1.08 |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 1.04 |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 0.87 |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 1.16 |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 1.51 |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 0.95 |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 0.73 |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 1.11 |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 1.21 |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 0.73 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 0.73 |
| Jan 31, 2026 | 0.65 |
| Oct 31, 2025 | 0.66 |
| Jul 31, 2025 | 0.67 |
| Apr 30, 2025 | 0.64 |
| Jan 31, 2025 | 0.59 |
| Oct 31, 2024 | 0.58 |
| Jul 31, 2024 | 0.65 |
| Apr 30, 2024 | 0.72 |
| Jan 31, 2024 | 0.77 |
| Oct 31, 2023 | 0.84 |
| Jul 31, 2023 | 0.90 |
| Apr 30, 2023 | 0.86 |
| Jan 31, 2023 | 0.85 |
| Oct 31, 2022 | 0.95 |
| Jul 31, 2022 | 1.01 |
| Apr 30, 2022 | 0.97 |
| Jan 31, 2022 | 0.90 |
| Oct 31, 2021 | 0.77 |
| Jul 31, 2021 | 0.69 |